Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 12/20 | 0.56 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.56 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.56 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | EDNRB | P24530 | 2/20 | 0.39 |
| ▸ | EDNRA | P25101 | 2/20 | 0.39 |
| ▸ | CCKBR | P32239 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6616008 | 0.91 | HSD11B1 (0.64) | HSD11B1HSD17B1HSD17B2SLC40A1CCKBR | |
| SCHEMBL6616875 | 0.90 | HSD11B1 (0.66) | HSD11B1HSD17B1HSD17B2SLC40A1CCKBR | |
| SCHEMBL6615038 | 0.89 | HSD11B1 (0.57) | HSD11B1HSD17B1HSD17B2SLC40A1MAPK1 | |
| SCHEMBL6689111 | 0.88 | HSD11B1 (0.54) | HSD11B1HSD17B1HSD17B2SLC40A1MAPK1 | |
| SCHEMBL6624322 | 0.88 | HSD11B1 (0.55) | HSD11B1HSD17B1HSD17B2SLC40A1EDNRB | |
| SCHEMBL6611463 | 0.88 | HSD11B1 (0.55) | HSD11B1HSD17B1HSD17B2SLC40A1MAPK1 | |
| SCHEMBL6609592 | 0.81 | HSD11B1 (0.50) | HSD11B1HSD17B1HSD17B2SLC40A1F2 | |
| SCHEMBL6610782 | 0.80 | HSD11B1 (0.49) | HSD11B1HSD17B1HSD17B2SLC40A1F2 | |
| SCHEMBL6611882 | 0.79 | HSD11B1 (0.45) | HSD11B1HSD17B1HSD17B2CCKBR | |
| SCHEMBL6614236 | 0.79 | HSD11B1 (0.48) | HSD11B1HSD17B1HSD17B2SLC40A1F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019075394-A1 | COMPOUNDS FOR TREATMENT OF EMOTIONAL/PSYCHOLOGICAL SYMPTOMS IN FRAGILE X SYNDROME | VANDERKLISH PETER (US) | 2019-04-18 | — | — | WO | disclosed |